Clear Vision Ahead: Astellas Pharma’s Billion-Dollar Investment in Blindness and Regeneration
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration' In recent news, ...
Read moreAstellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration' In recent news, ...
Read moreNeuralink co-founder has revealed plans for an eye implant that one day will be possible to ...
Read moreTech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]